Known targets — ChEMBL curated mechanism
ACEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ATP4AATP4BAXLBTKCACNA1CCACNA1DCACNA1FCACNA1SCCR5CHRM2CHRM3CPT1BCPT2DPP4DRD1DRD2EGFRERBB2ERBB4FLT3HRH1HRH3HTR1AHTR2AHTR2BHTR2CHTR4JAK1JAK2JAK3KCNH2KMT2AMAP2K1MAP2K2MEN1MLNRMPLMTORPPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PLK4PPARGRENS1PR1SLC6A2SLC6A3SLC6A4SMOTYK2atpAatpBatpCatpDatpEatpFatpFHatpGpol
The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2C known ✓ | P28335 | 6/20 | 0.38 |
| ▸ | HTR2B known ✓ | P41595 | 3/20 | 0.38 |
| ▸ | HTR2A known ✓ | P28223 | 1/20 | 0.33 |
| ▸ | MEN1 known ✓ | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A known ✓ | Q03164 | 1/20 | 0.33 |
| ▸ | PRCP | P42785 | 3/20 | 0.46 |
| ▸ | TLR2 | O60603 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | TERT | O14746 | 1/20 | 0.33 |
| ▸ | MAPK14 | Q16539 | 2/20 | 0.33 |
| ▸ | CCNK | O75909 | 1/20 | 0.33 |
| ▸ | CDK12 | Q9NYV4 | 1/20 | 0.33 |
| ▸ | MITF | O75030 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9348697 | 0.85 | PRCP (0.57) | PRCPHTR2CHTR2BTLR2KDM4E | |
| SCHEMBL13396336 | 0.84 | PRCP (0.59) | PRCPHTR2CHTR2BTLR2KDM4E | |
| Fumaric Acid SCHEMBL6380885 | 0.78 | CA12 (0.33) | PRCPTLR2MEN1MITFLMNA | |
| Maleic Acid SCHEMBL6380880 | 0.78 | CA12 (0.33) | PRCPTLR2MEN1MITFLMNA | |
| Fumaric Acid SCHEMBL6373847 | 0.78 | MEN1 (0.33) | PRCPMEN1MITFLMNATP53 | |
| Maleic Acid SCHEMBL6373843 | 0.78 | MEN1 (0.33) | PRCPMEN1MITFLMNATP53 | |
| SCHEMBL9330344 | 0.74 | MEN1 (0.36) | PRCPMEN1ALOX15KMT2A | |
| Hydrochloric Acid SCHEMBL25328307 | 0.73 | PRCP (0.55) | PRCPHTR2CHTR2BTLR2KDM4E | |
| SCHEMBL15329272 | 0.73 | PRCP (0.70) | PRCPHTR2CHTR2BTLR2KDM4E | |
| Fumaric Acid SCHEMBL9346156 | 0.73 | MAPT (0.39) | KDM4EMEN1LMNACYP3A4MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5280031-A | Cyclic azaaliphatic compounds with a nitroxy function, processes for the preparation thereof and pharmaceutical compositions containing them | BOEHRINGER MANNHEIM GMBH (DE) | 1994-01-18 | — | — | US | disclosed |
| US-5030641-A | Treatment of angina pectoris, hypotensive agents | BOEHRINGER MANNHEIM GMBH (DE) | 1991-07-09 | — | — | US | disclosed |